×
Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    Europe Bioreactors Market Forecast 2028 By Product Type (Single-use, Reusable), By Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy), By Cell (Mammalian Cells, Bacterial Cells, Yeast Cells), By End-use (R&D Organizations, Biopharma Manufacturers, CMOs), Research Report, Country Outlook (Germany, UK, Spain, Italy, France, Netherlands, Denmark, Russia, Poland, Sweden, Norway), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
    Published Date: November 2022   |   Report ID: GR1233   |   Delivery: PDF  Request Free Sample

    Report Content

    Chapter 1   Methodology & Scope

    1.1    Definitions and forecast parameters

    1.1.1    Definitions

    1.1.2    Methodology and forecast parameters

    1.2    Data sources

    1.2.1    Secondary

    1.2.2    Primary

    Chapter 2   Executive Summary

    2.1    Europe bioreactors industry summary, 2017-2028

    2.1.1    Country trends

    2.1.2    Product type trends

    2.1.3    Cell trends

    2.1.4    Molecule trends

    2.1.5    Usage trends

    2.1.6    End-user trends

    Chapter 3   Industry Insights

    3.1    Industry segmentation

    3.2    Industry landscape, 2017-2028 (USD Million)

    3.3    Major factor analysis

    3.3.1    Drivers

    3.3.1.1   Increasing government funding for vaccine development

    3.3.1.2   Technological advancements in bioreactor industry

    3.3.1.3   Increasing number of pharmaceutical and biotechnology companies

    3.3.1.4   Rising demand for personalized medicine

    3.3.2    Industry pitfalls and challenges

    3.3.2.1   Limited storage capacity of single-use bioreactor

    3.4    Analysis of COVID-19 impact on the industry

    3.5    Porter’s analysis

    3.6    Competition review, 2021

    3.7    PEST analysis

    Chapter 4   Europe Bioreactors Market, By Product Type

    4.1    Market trends

    4.2    Single use

    4.2.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    4.3    Reusable

    4.3.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    Chapter 5   Europe Bioreactors Market, By Cell

    5.1    Market trends

    5.2    Mammalian cells

    5.2.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    5.3    Bacterial cells

    5.3.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    5.4    Yeast cells

    5.4.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    5.5    Others

    5.5.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    Chapter 6   Europe Bioreactors Market, By Molecule

    6.1    Market trends

    6.2    Monoclonal antibodies

    6.2.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    6.3    Vaccines

    6.3.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    6.4    Recombinant proteins

    6.4.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    6.5    Stem cells

    6.5.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    6.6    Gene therapy

    6.6.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    6.7    Others

    6.7.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    Chapter 7   Europe Bioreactors Market, By Usage

    7.1    Market trends

    7.2    Developmental, pre-clinical & clinical

    7.2.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    7.3    Commercial production

    7.3.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    Chapter 8   Europe Bioreactors Market, By End-user

    8.1    Market trends

    8.2    R&D organizations

    8.2.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    8.3    Biopharma manufacturers

    8.3.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    8.4    Contract manufacturing organizations (CMOs)

    8.4.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    Chapter 9   Europe Bioreactors Market, By Country

    9.1    Market trends

    9.2    Germany

    9.2.1    Market estimates and forecast, by product type, 2017-2028 (USD Million)

    9.2.2    Market estimates and forecast, by cell, 2017-2028 (USD Million)

    9.2.3    Market estimates and forecast, by molecule, 2017-2028 (USD Million)

    9.2.4    Market estimates and forecast, by usage, 2017-2028 (USD Million)

    9.2.5    Market estimates and forecast, by end-user, 2017-2028 (USD Million)

    9.3    UK

    9.3.1    Market estimates and forecast, by product type, 2017-2028 (USD Million)

    9.3.2    Market estimates and forecast, by cell, 2017-2028 (USD Million)

    9.3.3    Market estimates and forecast, by molecule, 2017-2028 (USD Million)

    9.3.4    Market estimates and forecast, by usage, 2017-2028 (USD Million)

    9.3.5    Market estimates and forecast, by end-user, 2017-2028 (USD Million)

    9.4    Spain

    9.4.1    Market estimates and forecast, by product type, 2017-2028 (USD Million)

    9.4.2    Market estimates and forecast, by cell, 2017-2028 (USD Million)

    9.4.3    Market estimates and forecast, by molecule, 2017-2028 (USD Million)

    9.4.4    Market estimates and forecast, by usage, 2017-2028 (USD Million)

    9.4.5    Market estimates and forecast, by end-user, 2017-2028 (USD Million)

    9.5    Italy

    9.5.1    Market estimates and forecast, by product type, 2017-2028 (USD Million)

    9.5.2    Market estimates and forecast, by cell, 2017-2028 (USD Million)

    9.5.3    Market estimates and forecast, by molecule, 2017-2028 (USD Million)

    9.5.4    Market estimates and forecast, by usage, 2017-2028 (USD Million)

    9.5.5    Market estimates and forecast, by end-user, 2017-2028 (USD Million)

    9.6    France

    9.6.1    Market estimates and forecast, by product type, 2017-2028 (USD Million)

    9.6.2    Market estimates and forecast, by cell, 2017-2028 (USD Million)

    9.6.3    Market estimates and forecast, by molecule, 2017-2028 (USD Million)

    9.6.4    Market estimates and forecast, by usage, 2017-2028 (USD Million)

    9.6.5    Market estimates and forecast, by end-user, 2017-2028 (USD Million)

    9.7    The Netherlands

    9.7.1    Market estimates and forecast, by product type, 2017-2028 (USD Million)

    9.7.2    Market estimates and forecast, by cell, 2017-2028 (USD Million)

    9.7.3    Market estimates and forecast, by molecule, 2017-2028 (USD Million)

    9.7.4    Market estimates and forecast, by usage, 2017-2028 (USD Million)

    9.7.5    Market estimates and forecast, by end-user, 2017-2028 (USD Million)

    9.8    Denmark

    9.8.1    Market estimates and forecast, by product type, 2017-2028 (USD Million)

    9.8.2    Market estimates and forecast, by cell, 2017-2028 (USD Million)

    9.8.3    Market estimates and forecast, by molecule, 2017-2028 (USD Million)

    9.8.4    Market estimates and forecast, by usage, 2017-2028 (USD Million)

    9.8.5    Market estimates and forecast, by end-user, 2017-2028 (USD Million)

    9.9    Russia

    9.9.1    Market estimates and forecast, by product type, 2017-2028 (USD Million)

    9.9.2    Market estimates and forecast, by cell, 2017-2028 (USD Million)

    9.9.3    Market estimates and forecast, by molecule, 2017-2028 (USD Million)

    9.9.4    Market estimates and forecast, by usage, 2017-2028 (USD Million)

    9.9.5    Market estimates and forecast, by end-user, 2017-2028 (USD Million)

    9.10    Poland

    9.10.1    Market estimates and forecast, by product type, 2017-2028 (USD Million)

    9.10.2    Market estimates and forecast, by cell, 2017-2028 (USD Million)

    9.10.3    Market estimates and forecast, by molecule, 2017-2028 (USD Million)

    9.10.4    Market estimates and forecast, by usage, 2017-2028 (USD Million)

    9.10.5    Market estimates and forecast, by end-user, 2017-2028 (USD Million)

    9.11    Sweden

    9.11.1    Market estimates and forecast, by product type, 2017-2028 (USD Million)

    9.11.2    Market estimates and forecast, by cell, 2017-2028 (USD Million)

    9.11.3    Market estimates and forecast, by molecule, 2017-2028 (USD Million)

    9.11.4    Market estimates and forecast, by usage, 2017-2028 (USD Million)

    9.11.5    Market estimates and forecast, by end-user, 2017-2028 (USD Million)

    9.12    Norway

    9.12.1    Market estimates and forecast, by product type, 2017-2028 (USD Million)

    9.12.2    Market estimates and forecast, by cell, 2017-2028 (USD Million)

    9.12.3    Market estimates and forecast, by molecule, 2017-2028 (USD Million)

    9.12.4    Market estimates and forecast, by usage, 2017-2028 (USD Million)

    9.12.5    Market estimates and forecast, by end-user, 2017-2028 (USD Million)

    Chapter 10   Company Profiles

    10.1    Applikon Biotechnology, Inc. (Getinge)

    10.1.1    Business overview

    10.1.2    Financial data

    10.1.3    Product landscape

    10.1.4    Strategic outlook

    10.2    Bbi-biotech

    10.2.1    Business overview

    10.2.2    Financial data

    10.2.3    Product landscape

    10.2.4    Strategic outlook

    10.3    Cellexus Limited

    10.3.1    Business overview

    10.3.2    Financial data

    10.3.3    Product landscape

    10.3.4    Strategic outlook

    10.4    CerCell Aps

    10.4.1    Business overview

    10.4.2    Financial data

    10.4.3    Product landscape

    10.4.4    Strategic outlook

    10.5    Eppendorf AG

    10.5.1    Business overview

    10.5.2    Financial data

    10.5.3    Product landscape

    10.5.4    Strategic outlook

    10.6    Cytiva (Danaher Corporation)

    10.6.1    Business overview

    10.6.2    Financial data

    10.6.3    Product landscape

    10.6.4    Strategic outlook

    10.7    GEA Group Aktiengesellschaft

    10.7.1    Business overview

    10.7.2    Financial data

    10.7.3    Product landscape

    10.7.4    Strategic outlook

    10.8    Merck Group

    10.8.1    Business overview

    10.8.2    Financial data

    10.8.3    Product landscape

    10.8.4    Strategic outlook

    10.9    Pierre Guerin SAS

    10.9.1    Business overview

    10.9.2    Financial data

    10.9.3    Product landscape

    10.9.4    Strategic outlook

    10.10    Sartorius Stedim Biotech Group

    10.10.1    Business overview

    10.10.2    Financial data

    10.10.3    Product landscape

    10.10.4    Strategic outlook

    10.11    Solaris Biotech Solutions

    10.11.1    Business overview

    10.11.2    Financial data

    10.11.3    Product landscape

    10.11.4    Strategic outlook

    10.12    Thermo Fisher Scientific Inc.

    10.12.1    Business overview

    10.12.2    Financial data

    10.12.3    Product landscape

    10.12.4    Strategic outlook

    10.13    Solida Biotech

    10.13.1    Business overview

    10.13.2    Financial data

    10.13.3    Product landscape

    10.13.4    Strategic outlook


    Get this research report on Europe Bioreactors Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team

      (+1)-208-273-9852

     [email protected]